Table 2.

Relationship between sCLU levels and clinicopathological factors in 1998 IBC patients

Group	sCLU level (μg/mL)	P-value
Age (years)		0.089
<50	78.9 ± 11.6
≥50	81.3 ± 11.7
Tumor size		0.163
≤ 2 cm	77.7 ± 10.3
>2 cm	80.4 ± 11.5
Grade		0.251
G1-G1	78.3 ± 12.4
G3	80.6 ± 11.8
Clinical Stages		<0.0001
I–II	56.4 ± 12.8
III	92.6 ± 13.8
Lymph metastasis		<0.0001
Yes	89.7 ± 12.6
No	60.4 ± 11.8
Distant metastasis		0.173
Yes	82.6 ± 13.5
No	78.4 ± 12.7
Subtype		0.494
Luminal A	78.5 ± 12.7
Luminal B	77.6 ± 13.1
HER2 (+)	81.6 ± 13.6
Triple negative	82.6 ± 12.7
Menopause		0.560
Yes	79.0 ± 12.5
No	79.8 ± 12.2
ER		0.137
Positive(+)	81.6 ± 12.5
Negative(-)	78.4 ± 12.5
PR		0.382
Positive(+)	78.4 ± 11.8
Negative(-)	80.9 ± 12.6